Get startedLog in
    Picture of Calliditas Therapeutics AB logo

    CALT — Calliditas Therapeutics AB News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapMomentum Trap
    All News

    Brief: Calliditas' Partner Everest Medicines Announces China NMPA's Approval

    Picture of Calliditas Therapeutics AB logoCalliditas Therapeutics AB
    24/11/2023 08:00
    Nov 24 (Reuters) - Calliditas Therapeutics AB
 CALTX.ST :
    * CALLIDITAS' PARTNER EVEREST MEDICINES ANNOUNCES CHINA
NMPA'S
APPROVAL OF NEFECON FOR TREATMENT OF PRIMARY IGA NEPHROPATHY
    * APPROVAL TRIGGERS MILESTONE PAYMENT OF FIVE MILLION USD,
WHICH
WILL BE INCLUDED AS REVENUE IN Q4

Source text for Eikon:  ID:nWkr4vMd3L 
Further company coverage:  CALTX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Calliditas Therapeutics AB

    See all news